These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8907572)

  • 21. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
    Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
    Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.
    Sitzmann JV; Bulkley GB; Mitchell MC; Campbell K
    Ann Surg; 1989 Mar; 209(3):322-7. PubMed ID: 2493776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptide receptors in human artery and vein and rabbit vein graft.
    Ikeda T; Itoh H; Komatsu Y; Hanyu M; Yoshimasa T; Matsuda K; Nakao K; Ban T
    Hypertension; 1996 Mar; 27(3 Pt 2):833-7. PubMed ID: 8613249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
    Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
    Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
    Ganger DR; Gottstein J; Blei AT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells.
    Kato J; Misko TP; Currie MG
    Eur J Pharmacol; 1993 Jan; 244(2):153-9. PubMed ID: 7679351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension.
    Thomas SH; Joh T; Benoit JN
    Dig Dis Sci; 1991 Sep; 36(9):1243-8. PubMed ID: 1893807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension.
    Sitzmann JV; Li SS; Lin PW
    J Surg Res; 1989 Sep; 47(3):208-11. PubMed ID: 2504995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.
    Pizcueta MP; Piqué JM; Bosch J; Whittle BJ; Moncada S
    Br J Pharmacol; 1992 Jan; 105(1):184-90. PubMed ID: 1596680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial natriuretic peptide: binding and cyclic GMP response in cultured vascular smooth muscle cells from spontaneously hypertensive rats.
    Resink TJ; Scott-Burden T; Jones CR; Baur U; Bühler FR
    Am J Hypertens; 1989 Jan; 2(1):32-9. PubMed ID: 2536544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal hemodynamics and humoral factors involved in a portal hypertensive rabbit model.
    Lin PW; Shan YS
    Proc Natl Sci Counc Repub China B; 1995 Oct; 19(4):240-5. PubMed ID: 8742622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference in effect of atrial natriuretic peptide on cGMP in aortic and coronary smooth muscle cells.
    Newman WH; Kato J; Becker BF; Currie MG
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H710-4. PubMed ID: 1329536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP.
    Zhang LM; Tao H; Newman WH
    Am J Physiol; 1993 Jun; 264(6 Pt 2):H1753-9. PubMed ID: 8391754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.